Zhengqi Jiang ∙ Tichao Shan∙ Yucan Li ∙ Heyu Ni ∙ et. al., DOI: 10.1016/j.ijid.2025.108287 External Link Also available on ScienceDirect External Link Highlights SARS-CoV-2 causes lasting immune dysregulation for over 20 months. The impact of SARS-CoV-2 on lymphocytes was especially severe in patients […]
Hematological Markers as Predictors of ICU Admission in COVID-19 Patients: A Case-Control Study From a Tertiary Hospital
Nor Hayati Ismail • Alaa Siddig • Muhammad ‘Akif, et. al. Published: July 10, 2024, DOI: 10.7759/cureus.64213 Abstract Background: COVID-19 illness severity ranges from mild- to life-threatening cases necessitating critical care. Rapid prediction of disease severity […]
Clinical Significance of CBC and WBC Morphology in the Diagnosis and Clinical Course of COVID-19 Infection
Olga Pozdnyakova, MD, PhD, Nathan T Connell, MD, MPH, Elisabeth M Battinelli, MD, PhD, Jean M Connors, MD, Geoffrey Fell, MS, Annette S Kim, MD, PhD, American Journal of Clinical Pathology, Volume 155, Issue 3, […]
COVID-19 Can Remain Undetected In Lungs For 18 Months: Study
DEC 14, 2023 – Authored by Amie Dahnke via The Epoch Times The COVID-19 virus can remain in the lungs for months after an individual has been infected—even though it […]
Multi-layered transcriptomic analyses reveal an immunological overlap between COVID-19 and hemophagocytic lymphohistiocytosis associated with disease severity
Authors: Lena F. Schimkea,5, Alexandre H.C. Marquesa, Gabriela Crispim Baiocchia, Caroline Aliane de Souza Pradob Dennyson Leandro M. Fonsecab , Paula Paccielli Freirea , Desirée Rodrigues Plaçab , Igor Salerno […]
Pre-existing immunity to SARS-CoV-2: the knowns and unknowns
Authors: Alessandro Sette 1 2, Shane Crotty 3 4 Abstract T cell reactivity against SARS-CoV-2 was observed in unexposed people; however, the source and clinical relevance of the reactivity remains unknown. It is speculated that […]